Submission Details
| 510(k) Number | K232943 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 20, 2023 |
| Decision Date | May 31, 2024 |
| Days to Decision | 254 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K232943 is an FDA 510(k) clearance for the Hypodermic Needle-Pro? EDGE? Safety Device with Low Dead Space Syringe, a Low Dead Space Piston Syringe (Class II — Special Controls, product code QNQ), submitted by Smiths Medical Asd, Inc. (Plymouth, US). The FDA issued a Cleared decision on May 31, 2024, 254 days after receiving the submission on September 20, 2023. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5860.
| 510(k) Number | K232943 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 20, 2023 |
| Decision Date | May 31, 2024 |
| Days to Decision | 254 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | QNQ — Low Dead Space Piston Syringe |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5860 |
| Definition | A Low Dead Space Syringe Is A Piston Syringe Designed To Reduce Medication Waste. The Device Consists Of A Calibrated Hollow Barrel, A Moveable Plunger, And May Include A Needle. The Device Can Be Used By Health Care Professions Or For Self-injection By The Patient. |